Women's Health

Choose Your Cover: Free Skin Cancer Screenings

Join us for a FREE skin cancer screening courtesy of Hackensack Meridian Health and Ocean Monmouth Health Alliance.

June 9 | 10 a.m. - 3 p.m.
Meridian Community Resource Center at Freehold Raceway Mall

June 13 | 5 - 7 p.m.
Jersey Shore University Medical Center

July 15 | 10 a.m. - 2 p.m.
Brick Beach III, Route 35 North
Brinley Avenue Boardwalk, Bradley Beach
Robert D. Wilson Memorial Community Center
22 Snug Harbor Ave., Highlands
20th Street Beach Entrance
Ship Bottom with Long Beach Island Health Department

For more information or to register, please call 1-800-560-9990 or visit our online events calendar.


Paint the Town Pink Forum

Please join us at our annual Paint the Town Pink open forum about the importance of annual mammograms, overall gynecologic health, screening guidelines and treatment options. Our team of multidisciplinary physicians will discuss the best team approach to cancer care. Door prizes will be provided and a light dinner will be served. Come Pink On with us!

June 19, 2017 | 5:30 - 7 p.m.
Hackensack Meridian Health Village, Jackson
Speakers: Yolanda Tammaro, M.D.; Stuti Ahlawat, M.D. and Susan Greenberg, M.D.

Registration is required and available by calling 1-800-PINK-411.


Osteoporosis in Women

Learn the signs, symptoms, diagnosis and treatment options for osteoporosis, including exercise, vitamins and diet. Bone density screenings provided.

July 25, 6:30 – 8 p.m.
Jersey Shore University Medical Center
Brennan Rooms 104/105
Speaker: Rebecca Cipriano, M.D.

August 10, 6:30 – 7:30 p.m.
Meridian Community Resource Center at Freehold Raceway Mall

blog image
Women's Health

Exposure to fine-particle air pollution linked to dense breast tissue, a risk factor for tumors, study finds

Read more
blog image
Women's Health

Study found life expectancy differed by as much as 20 years in different counties

Read more
blog image
Women's Health

Study finds that most still recommend the breast cancer screen for women in their early 40s

Read more

Zejula Approved for Certain Female Cancers

TUESDAY, March 28, 2017 -- Zejula (niraparib) has been approved by the U.S. Food and Drug Administration to treat adult women with recurring cancers of the ovaries, fallopian tubes or abdominal wall (peritoneum) whose tumors have shrunk in response to platinum-based chemotherapy.

Citing the National Cancer Institute, the FDA said in a news release that more than 22,000 women are expected to be diagnosed with these cancers this year, and more than 14,000 will die of these diseases.

Read more